The Ledger
Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.
why aren't all 7 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 1 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable
Dave Morin: Ozempic costs $1,200 in US versus $100 in Mexico
“Yeah, it's 1200 dollars a month. It's a hundred dollars a month in Mexico, so the American health system is causing a 90% markup.”
Sam Lessin: Ozempic is going to run out of user growth
“I think what it's worth is very bearish on Ozempic, because they're gonna run out of people. They're just gonna run out of growth.”
Sam Lessin: Ozempic is a real-life face filter for rich people
“Well, just that like Ozempic is like, is rich people face filters, right? Cause it's like, it's more expensive. It's in person. Anyone can look good on the internet, but not anyone can look good in real life. So this actually relates to our body thing too, but…”
Jessica Lessin: Taking GLP-1 weight-loss drugs without long-term studies is highly risky
“Even if we have these studies, we have no long-term benefits or studies on this stuff. And, like, it just seems highly risky to me, I gotta say. Highly risky.”
Brit Morin: Clinical trial shows semaglutide reduces cardiovascular risk by 20%
“There was a new paper that came out that actually proved that there is a reduction of heart attack and stroke risk by 20% for those that have used Ozempic”